Cidel Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,000
Closed -$370K 113
2019
Q1
$370K Buy
+15,000
New +$358K 0.02% 99
2015
Q4
Sell
-678,000
Closed -$121M 84
2015
Q3
$121M Sell
678,000
-42,100
-6% -$9.82M 7.62% 3
2015
Q2
$200M Sell
720,100
-75,200
-9% -$16.7M 8.72% 2
2015
Q1
$157M Sell
795,300
-178,811
-18% -$31.7M 8.08% 2
2014
Q4
$140M Buy
+974,111
New +$131M 6.63% 3

Other funds holding BHC

Cidel Asset Management's BHC Position: Q2 2019 in Review

Cidel Asset Management sold out of Bausch Health (BHC) in Q2 2019, closing a stake of 15,000 shares — an estimated $370K sold.

Cidel Asset Management first reported a position in BHC in Q4 2014 and held it in 5 quarters. The position peaked at $200M in Q2 2015. 332 funds tracked by Wall St. Rank hold BHC as of Q2 2019.

  • Cidel Asset Management reported no remaining Bausch Health position as of Q2 2019 after selling out during the quarter.
  • Cidel Asset Management sold 15,000 Bausch Health shares in Q2 2019, an estimated $370K.
  • Cidel Asset Management first reported a position in Bausch Health in Q4 2014 and held it in 5 quarters.
  • Cidel Asset Management's Bausch Health position peaked at $200M in Q2 2015.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q2 2019.

Based on Cidel Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.